In the article by Reynolds et al, “Cost-Effectiveness of Transcatheter Aortic Valve Replacement Compared With Standard Care Among Inoperable Patients With Severe Aortic Stenosis: Results From the Placement of Aortic Transcatheter Valves (PARTNER) Trial (Cohort B),” which appeared in the March 6, 2012 issue of the journal (Circulation. 2012;125:1102–1109), Dr William W. O’Neill failed to disclose a professional relationship with Edwards Lifesciences, Inc.
The current online version of the article has been corrected. The authors apologize for the omission.
- © 2013 American Heart Association, Inc.